Skin Models pp 140-146 | Cite as

Experimental Contact Dermatitis Using 2,4-Dinitrochlorobenzene in Humans

  • J. A. A. Hunter
  • M. M. Carr
  • P. A. Botham
  • D. J. Gawkrodger
  • E. McVittie
  • J. A. Ross
  • I. C. Stewart
Conference paper


Contact dermatitis, due to both allergenic (sensitising) and irritant (non-sensitising) agents is a major clinical problem in industry and the home. Although its prevalence in a population depends on the nature of employment and industry, and environmental factors, it has been shown that one type of contact dermatitis alone, hand eczema, affects 2% of men and 3% of women [1]. Industrial dermatitis in fact accounts for about 65% of all spells of absence from work in the United Kingdom recorded under prescribed diseases [9].


Contact Dermatitis Alopecia Areata Bronchogenic Carcinoma Cutaneous Contact Contact Allergic Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Agrup G (1969) Hand eczema and other hand dermatoses in Sweden. Acta Derm Venereol (Stockh) 49: 1–91Google Scholar
  2. 2.
    Ames BN, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutation Res 31: 347–374PubMedGoogle Scholar
  3. 3.
    Ashby J (1983) The unique role of rodents in the detection of possible human carcinogens and mutagens. Mutation Res 115: 177–213PubMedGoogle Scholar
  4. 4.
    Buckner D, Price NM (1978) Immunotherapy of verrucae vulgares with dinitrochlorobenzene. Br. J Dermatol 98: 451–454Google Scholar
  5. 5.
    Carr MM, Botham PH, Gawkrodger DJ, McVittie E, Ross JA, Stewart IC, Hunter JAA (1984) Early cellular reactions induced by dinitrochlorobenzene in sensitised human skin. Br J Dermatol 110: 631–641CrossRefGoogle Scholar
  6. 6.
    Catalona WB, Taylor P, Rabson A, Chretien P (1972) A method for dinitrochlorobenzene contact sensitization. A clinico-pathological study. New Engl J Med 286: 399Google Scholar
  7. 7.
    Eriksen K (1978) Cross allergy between paranitro compounds with special reference to DNCB and chloramphenicol. Contact Dermatitis 4: 29–32PubMedCrossRefGoogle Scholar
  8. 8.
    Happle R, Cebulla K, Echternacht-Happle K (1978) Dinitrochlorobenzene therapy for alopecia areata. Arch Dermatol 114: 1629–1631PubMedCrossRefGoogle Scholar
  9. 9.
    Office of Health Economics (1973) Skin Disorders O.H. E. Publication No 46: 10Google Scholar
  10. 10.
    Polak L (1980) Monographs in Allergy, vol 15. Immunological Aspects of Contact Sensitivity. KargerGoogle Scholar
  11. 11.
    Silberberg I (1973) Apposition of mononuclear cells to Langerhans cells in contact allergic reactions. An ultrastructural study. Acta Derm Venerol (Stockh) 53: 1–12Google Scholar
  12. 12.
    Silberberg-Sinakin I, Thorbecke GJ (1980) Contact hypersensitivity and Langerhans cells. Acta Derm Venerol (Stockh) 75: 61–67Google Scholar
  13. 13.
    Strauss GH, Bridges BA, Greaves M, Hall-Smith P, Price M, Vella-Briffa D (1980) Inhibition of delayed hypersensitivity reaction in skin (DNCB) test by 8-methoxypsoralen photochemotherapy. Lancet ii: 556Google Scholar
  14. 14.
    Weisburger EK, Russfield AB, Hamburger F, Weisburger JH, Boger E, Van Dougen CG, Chu KC (1978) Testing of twenty-one environmental aromatic amines or derivatives for long-term toxicity or carcinogenicity. J Environ Path Tox 2: 325–356Google Scholar
  15. 15.
    Wolff K, Stingl G (1983) The Langerhans cell. J Invest Dermatol 80:17S–21S (Suppl)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • J. A. A. Hunter
  • M. M. Carr
  • P. A. Botham
  • D. J. Gawkrodger
  • E. McVittie
  • J. A. Ross
  • I. C. Stewart

There are no affiliations available

Personalised recommendations